Many possible therapeutic targets, such as vascular endothelial growth factor (VEGF) and IL-13 receptor α2 (IL-13Rα2), have been discovered, as the mechanistic research probes deeper to elucidate the nature of glioma. This evidence concerns the gene VEGFA and central nervous system cancer.